文献速递前列腺癌

机器人前列腺切除术后不良病理特征预测列线图的开发与外部验证:一项前瞻性、多机构、全国性系列研究结果

Development and External Validation of Nomograms To Predict Adverse Pathological Characteristics After Robotic Prostatectomy: Results of a Prospective, Multi-institutional, Nationwide series.
PubMed 文献 · Eur Urol Oncol · 2018-06-07

该研究基于比利时癌症登记处2009至2016年前瞻性收集的25家学术与社区医院6823例机器人辅助腹腔镜前列腺切除术(RALP)患者数据,开发并外部验证了预测前列腺外侵犯(EPE)、精囊侵犯(SVI)及高级别局部晚期疾病(HGLA)的列线图。列线图对EPE、SVI、HGLA的区分准确度分别为77%、82%、88%,外部验证后保持稳定,校准特性优良。作者结论认为这些列线图可用于临床实践或临床试验患者选择。

要点

  • 基于6823例RALP患者的前瞻性多机构数据开发了预测EPE、SVI、HGLA的列线图。
  • 列线图对EPE、SVI、HGLA的区分准确度分别为77%、82%、88%。
  • 外部验证后准确度保持稳定,校准特性优良。

核心结论

  • 作者开发并外部验证了多机构列线图,用于预测RALP术后病理特征,可应用于临床实践或临床试验患者选择。

研究设计与样本

  • 前瞻性、多机构、全国性系列研究,2009至2016年由比利时癌症登记处收集25家学术与社区医院6823例接受RALP的患者数据。

主要发现

  • 列线图预测EPE、SVI、HGLA的区分准确度分别为77%、82%和88%。
  • 外部验证后列线图的准确度保持稳定。
  • 预测模型显示出优良的校准特性。

关键数值与推荐

  • 列线图基于以下术前协变量预测EPE(pT3a,b-4)、SVI(pT3b)和HGLA(pT3b-4且Gleason评分8-10):前列腺特异性抗原、临床T分期、穿刺Gleason评分和阳性穿刺针数百分比。
  • 使用80%队列进行十折交叉验证评估模型稳定性,并在测试队列中独立外部验证。
  • 区分准确度以受试者工作特征曲线下面积量化,并以校准图图形化展示。

临床怎么用

  • 作者结论认为这些列线图可应用于临床实践或用于临床试验的患者选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The possibility of predicting pathologic features before surgery can support clinicians in selecting the best treatment strategy for their patients. We sought to develop and externally validate pretreatment nomograms for the prediction of pathological features from a prospective multicentre series of robotic-assisted laparoscopic prostatectomy (RALP) procedures. DESIGN, SETTING, AND PARTICIPANTS: Between 2009 and 2016, data from 6823 patients undergoing RALP in 25 academic and community hospitals were prospectively collected by the Belgian Cancer Registry. Logistic regression models were applied to predict extraprostatic extension (EPE; pT3a,b-4), seminal vesicle invasion (SVI; pT3b), and high-grade locally advanced disease (HGLA; pT3b-4 and Gleason score [GS] 8-10) using the following preoperative covariates: prostate-specific antigen, clinical T stage, biopsy GS, and percentage of positive biopsy cores. Internal and external validation was performed. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The stability of the model was assessed via tenfold cross-validation using 80% of the cohort. The nomograms were independently externally validated using the test cohort. The discriminative accuracy of the nomograms was quantified as the area under the receiver operating characteristic curve and graphically represented using calibration plots. RESULTS AND LIMITATION: The nomograms predicting EPE, SVI, HGLA showed discriminative accuracy of 77%, 82%, and 88%, respectively. Following external validation, the accuracy remained stable. The prediction models showed excellent calibration properties. CONCLUSIONS: We developed and externally validated multi-institutional nomograms to predict pathologic features after RALP. These nomograms can be implemented in the clinical setting or patient selection in clinical trials. PATIENT SUMMARY: We developed novel nomograms using nationwide data to predict postoperative pathologic features and lethal prostate cancer.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Tosco L, De Coster G, Roumeguère T, et al. Development and External Validation of Nomograms To Predict Adverse Pathological Characteristics After Robotic Prostatectomy: Results of a Prospective, Multi-institutional, Nationwide series. Eur Urol Oncol. 2018. PMID: 31100256. doi:10.1016/j.euo.2018.04.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。